BioIndustry Association

#BioIndustry Association #Biotech #Financing #Investment #Venture funds

Q3 UK biotech VC heads for record year thanks to megadeals

UK biotech venture capital investment reached £270 million ($359 million), up 44% from £187 million ($248 million) in Q3 2025, according to new figures from the BioIndustry Association (BIA), as the sector heads for its best year since 2021.  The latest upswing comes as overall UK venture capital investment declines… Read More

#Business & Investment #Editor's Choice #News

Downing Street, London, UK
#Association of the British Pharmaceutical Industry #BioIndustry Association #UK economy

UK groups call on government to back life sciences ambitions in the Budget

Ahead of the Budget, UK life sciences groups have called on the Chancellor to prioritise investment in new medicines.  The UK government has set out bold targets for the UK’s life sciences sector. By 2030, it wants the UK to lead Europe in commercial research and development (R&D) investment, scale-up… Read More

#Business & Investment #News #Trending News

Great British Pounds, Investment
#BioIndustry Association #Biotechnology #Investment #UK

UK biotech venture investment reaches a five-year high

UK biotech financing hit a five-year high in the second quarter of 2026, with total equity financing reaching £2.11 ($2.84) billion, including a record £2.05 ($2.76) billion in venture capital, according to new figures from the BioIndustry Association (BIA).  The quarter was dominated by Isomorphic Labs’ landmark £1.6 ($2.1) billion… Read More

#Business & Investment #News

#BioIndustry Association #DDII #DDIIUK2026

Chris Molloy, BIA, keynotes Drug Discovery Innovators & Investors, UK Conference

We’re delighted to announce Chris Molloy, Chief Executive Officer of the UK BioIndustry Association (BIA), as keynote speaker at Drug Discovery Innovators & Investors, London, UK Conference. The conference theme, Technology, Speed, Scale, and Capital: Advancing UK Drug Discovery and Development, will bring together senior executives, R&D leaders, lab managers… Read More

#Editor's Choice #News

Big Ben and Houses of Parliament
#BioIndustry Association #Drug discovery #UK #UK government

UK life sciences industry calls on Government to boost innovation

With the upcoming change of Prime Minister, the UK’s life sciences sector has called on Government to deliver policy continuity, unlock scale-up investment and improve patient access to new medicines.  At a UK BioIndustry Association (BIA) industry roundtable with Dr Zubir Ahmed MP, the life sciences and biotech industry emphasised… Read More

#Business & Investment #News

#AstraZeneca #BioIndustry Association #Biotech #Boehringer Ingelheim #FDA #Gene therapy #Genetics #Hearing Loss #HIV #Investment #Malaria #Novartis #UK #WHO

DDW Highlights: 6 May 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, the UK made headlines for both the investment it has attracted and… Read More

#Podcasts

#AstraZeneca #BioIndustry Association #Biotech #Boehringer Ingelheim #FDA #Gene therapy #Genetics #Hearing Loss #HIV #Investment #Malaria #Novartis #UK #WHO

This week in Drug Discovery (27 April – 1 May) 

News round-up for 27 April – 1 May by Bruno Quinney, Content Team at DDW.  This week, the UK has made headlines for both the investment it has attracted and the clinical trial reforms it has rolled out. Elsewhere, the world’s first antimalarial drug for newborns could soon address a critical unmet… Read More

#News

Great British Pounds, Investment
#BioIndustry Association #Europe #Investment #UK

UK leads European biotech investment, BIA reports 

UK biotech led investment in the European market in the first quarter of 2026, new figures from the BioIndustry Association (BIA) show.  The BIA report shows renewed financing was driven by a rebound in venture capital investment and a broader distribution of funding across companies and stages. … Read More

#News

#Ascendis Pharma #BioIndustry Association #Cancer therapy #CHMP #Clinical trial #Diversity #European Medicines Agency #FDA #Gene therapy #Oncology #Paediatrics #Rare disease #uniQure #University of Queensland #Women in STEM

DDW Highlights: 10 March 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, figures showed the number of women in biotech leadership has stalled. Elsewhere, could… Read More

#Podcasts

Female CEO
#BioIndustry Association #Diversity #Women in STEM

Representation of women in biotech leadership stalls

Despite a marginal positive shift at CEO level, overall representation of women in leadership positions has stalled across the UK biotech sector, new figures have revealed.  The BioIndustry Association’s (BIA) report, ‘Women in Biotech Leadership: one year on’, combines PitchBook data with sector insights to track changes in representation across… Read More

#Business & Investment #Editor's Choice #News

Downing Street, London, UK
#BioIndustry Association #Life sciences #UK #UK government

UK government commits £1.5bn to life sciences  

The UK government has pledged £1.5 billion ($2.1 billion) for R&D in life sciences over the next four years.  Speaking at the BioIndustry Association (BIA)’s Gala Dinner, Liz Kendall, the Secretary of State for Science, Innovation and Technology, confirmed the funding for life sciences as part of the government’s… Read More

#News

Scientist in laboratory
#BioIndustry Association #Rare diseases #UK

Reform needed to give patients rare disease medicines 

The BioIndustry Association (BIA) has called for a new, reformed pathway to give UK patients access to innovative rare disease medicines.   According to the BIA’s new report, while the UK’s rare disease ecosystem has a solid foundation, more work is needed to build a connected, flexible and risk-proportionate access pathway to… Read More

#News

Japanese flag
#BioIndustry Association #Biotechnology #Collaboration #Japan Bioindustry Association

UK and Japan partner to advance biotech

The UK BioIndustry Association (BIA) and Japan Bioindustry Association (JBA) have signed a deal that aims to connect the two countries’ life sciences and biotech sectors to advance medical innovation and commercialise engineered biology. The countries memorandum of understanding (MOU) aims to establish new links between British and Japanese biotech… Read More

#Business & Investment #News

UK on global map
#BioIndustry Association #Oligonucleotides #UK

The UK should lead on oligonucleotides, says BIA

A new report from the BioIndustry Association (BIA) explains the UK’s leadership potential in oligonucleotide therapies.  The report ‘Oligos explainer: A new frontier in precision medicine’ highlights the transformative potential of oligonucleotide therapies.  The precision medicines, which use short DNA… Read More

#News

#BioIndustry Association #Biotech #Investment #Market reporting #UK

Buoyant UK biotech sector secures £1.8bn investment in 2023

The UK’s life sciences and biotech sector showed resilience in 2023, securing £1.8 ($2.2) billion in equity investment despite a challenging global economic climate, according to a report by the UK BioIndustry Association (BIA). This follows another BIA report in January 2024, which showed that the UK is a global… Read More

#Business & Investment #News

UK
#Advanced Therapies #BioIndustry Association #Cell and gene therapy #Cell and Gene Therapy Catapult #UK

UK maintains dominant global position in cell and gene therapy

The UK is cementing its position as a global leader in cell and gene therapy (CGT), according to a new report released today by the UK BioIndustry Association (BIA), in collaboration with Citeline. The report reveals a robust sector with significant investment, the highest number of… Read More

#News #Trending News